Compare First Trust NASDAQ Smart Grid ETF (GRID) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Trust NASDAQ Smart Grid ETF vs Halozyme Therapeutics Inc. Common Stock — how do they compare? First Trust NASDAQ Smart Grid ETF trades at $180 (market cap $12.13B), while Halozyme Therapeutics Inc. Common Stock trades at $109.92 (market cap $12.58B). The key difference: First Trust NASDAQ Smart Grid ETF and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, First Trust NASDAQ Smart Grid ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ Smart Grid ETF for 10 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| GRID | HALO | |
|---|---|---|
Market Cap | $12.13B | $12.58B |
Volume | 624,378 | 2,179,278 |
Sector | Sector/Thematic | Health |
52-Week High | $199.80 | $115.22 |
52-Week Low | $146.51 | $61.63 |
Typical Hold Time | 10 Days | 0 Days |
Enterprise Value | — | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About First Trust NASDAQ Smart Grid ETF
First Trust NASDAQ Smart Grid Infrastructure ETF seeks to track companies involved in smart grid and electricity infrastructure. Its holdings include businesses related to power networks, energy management, and grid technologies.
Read more on GRID →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
